Biomedical subjects

J S Whitaker

Publications and source records attributed to J S Whitaker.

2 recordsLinked to original sources

PubMed2001

On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction.

IC351 (Cialis) is a selective inhibitor of PDE5. The efficacy and safety of on-demand dosing of IC351 in men with erectile dysfunction was assessed in a multicenter, double-blind, placebo-controlled study. One hundred seventy-nine men (mean age: 56 y) were randomized to receive placebo or IC351 at doses of 2, 5, 10 or 25 mg, taken on demand over a 3-week period. The primary endpoints were change from baseline in responses to Questions 3 (Q3) and 4 (Q4) of the International Index of Erectile Function (IIEF). IC351 significantly improved IIEF Q3 scores at all doses vs placebo (P < or =0.003). IC351 also significantly improved IIEF Q4 scores in all but the 2 mg group (P < or =0.0003). No significant changes in laboratory values, ECGs, or blood pressure were observed. The most common adverse events were headache and dyspepsia. The conclusion of this study was that on-demand IC351 at doses up to 25 mg was well tolerated and significantly improved erectile function.

Adult↗

PubMed1984

Venous prostheses: improved patency with external stents.

A uniformly successful prosthesis for replacement in the venous system has not been developed. This study assesses the effect of external stents on the patency of polytetrafluoroethylene (PTFE) grafts in the infrarenal vena cava. Under general anesthesia, 21 mongrel dogs underwent midline laparotomy. The infrarenal vena cava was resected and replaced by a standard segment (8 cm X 10 mm) of stented PTFE (12 dogs) and nonstented PTFE (9 dogs). Patency was assessed by contrast venography and the results compared between the two groups. The 7-, 30-, and 90-day patency was 12/12, 10/12, and 9/12, respectively, for stented PTFE and 6/9, 2/9, and 2/9, respectively, for nonstented PTFE. The patency of externally stented PTFE at 30 and 90 days was significantly better than grafts fashioned from PTFE alone (P less than 0.05 by chi-square analysis). These data demonstrate that external stenting improves the early patency of PTFE prostheses in the infrarenal vena cava. Consideration should be given to the clinical use of externally stented PTFE when prosthetic replacement in the venous system is required.

Animals↗